Daily as of 3 Nov 16:00 ET
- Price
- below both $11.70 vs 50 $12.36 / 200 $16.41
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 17 Sep 2026 · projected 29 bars out
MLTX | MoonLake Immunotherapeutics Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$11.70
+$0.23 (+2.01%)
MoonLake Immunotherapeutics Class A (MLTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $11.78 vs 50 $16.06 / 200 $35.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 2 Feb 2026 · not projected
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $11.70 vs 50 $11.17 / 200 $15.52
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 18 Aug 2026 · projected 17 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 17 Sep 2026 | 💀Death steep | daily | 29 bars out | Not tested |
| 18 Aug 2026 | 💀Death | 4-hour | 17 bars out | Not tested |
| 25 Jun 2026 | 🟨Golden flat | daily | 27 bars out | — |
| 11 Feb 2026 | 🟨Golden | 4-hour | 30 bars out | — |
| week of 2 Feb 2026 | 💀Death | weekly | not projected | — |
About MLTX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$20.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall